comparemela.com

Latest Breaking News On - California based ionis - Page 1 : comparemela.com

Otsuka to commercialise hereditary angioedema drug in Europe

Otsuka to commercialise hereditary angioedema drug in Europe
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Ionis Posts Trial Data in Rare Disease That Position It to Finally Set Out on Its Own

Ionis Pharmaceuticals’ olezarsen has Phase 3 results showing the therapy handily beat a placebo at reducing fat levels in the blood due to a rare, inherited metabolic disorder with no FDA-approved drugs. Ionis plans early 2024 submissions for what could become the first medicine it commercializes without a partner.

Novartis Pays Ionis $60M to Expand Alliance on a Hot Target for Cardio Drugs

Novartis and Ionis, already partners in cardiovascular disease R&D, are expanding their alliance to see if they can develop a next-generation therapy offering efficacy and dosing advantages. But competitors are already in the mix with programs addressing the same cardiovascular disease target.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.